What is the role of VCAM-1 in ovarian cancer?

David A. Fishman, MD on behalf of The Mount Sinai Health System

Gynecologic Oncology

VCAM-1 is a receptor on the surface of activated endothelial and mesothelial cells. In instances of inflammation, it promotes white blood cell attachment and extravasation. There are reports of it being involved in metastasis of ovarian cancer. The effects of cytokines promoting angiogenesis have been shown to be potentiated by VCAM-1 in endothelial cells. As a soluble form of VCAM-1 is released from endothelial cells, it may prove useful in detecting early or pre-clinical ovarian cancer.

Continue Learning about Ovarian Cancer

6 Tips to Keep a Consistent Medication Routine

Many people living with cancer struggle to take medications as directed, for a variety of reasons. Use the tips in this video to help keep a consisten...

Ovarian Cancer Research Fund (OCRF)

The beginning location of ovarian cancer has eluded doctors. Scientists attempting to track down ear...

Dr. Jeanne Morrison, PhD

While you may not be able to prevent ovarian cancer, there are ways you can reduce your risk. Taking...

If a Woman Is Diagnosed with Breast Cancer, Does She Have a Risk for Ovarian Cancer?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.